Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Atrial fibrillation | 94 | 30 | |
Prevent blood clotting | 83 | 51 | |
Pulmonary embolism | 21 | 6 | |
Deep vein thrombosis | 5 | 3 | |
Antiphospholipid antibody syndrome | 3 | 5 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Bruising | 4 | |
Balance problems | 1 | |
Excessive bleeding | 1 | |
Fatigue | 1 | |
Leg cramps at night | 1 | |
Muscle spasms | 1 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 1 | |
Moderate | 3 | |
Mild | 10 | |
None | 62 |
Member evaluations
Farmami
evaluated on Oct 19, 2018
- Perceived effectiveness for atrial fibrillation: Can't tell
- Side effects: None
nacona
evaluated on Jan 08, 2017
- Perceived effectiveness for deep vein thrombosis: Major
- Side effects: None
jr42
evaluated on Aug 15, 2017
- Perceived effectiveness for Prevent blood clotting: Major
- Side effects: None